PLoS One. 2013 Oct 4;8(10):e75415.
Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension.
Price LC, Caramori G, Perros F, Meng C, Gambaryan N, Dorfmuller P, Montani D, Casolari P, Zhu J, Dimopoulos K, Shao D, Girerd B, Mumby S, Proudfoot A, Griffiths M, Papi A, Humbert M, Adcock IM, Wort SJ.
Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension.
Price LC, Caramori G, Perros F, Meng C, Gambaryan N, Dorfmuller P, Montani D, Casolari P, Zhu J, Dimopoulos K, Shao D, Girerd B, Mumby S, Proudfoot A, Griffiths M, Papi A, Humbert M, Adcock IM, Wort SJ.
Curr Hypertens Rep. 2013 Oct 12. [Epub ahead of print]
An Update on Medical Therapy for Pulmonary Arterial Hypertension.
Wu Y, O'Callaghan DS, Humbert M.
An Update on Medical Therapy for Pulmonary Arterial Hypertension.
Wu Y, O'Callaghan DS, Humbert M.
Pharmacol Ther. 2013 Oct 14. pii: S0163-7258(13)00207-6. doi: 10.1016/j.pharmthera.2013.10.002. [Epub ahead of print]
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Gunther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Sitbon O, Simonneau G, Humbert M.
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Gunther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Sitbon O, Simonneau G, Humbert M.
Eur Respir J. 2013 Oct 17. [Epub ahead of print]
Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy.
Montani D, Girerd B, Günther S, Riant F, Tournier-Lasserve E, Magy L, Maazi N, Guignabert C, Savale L, Sitbon O, Simonneau G, Soubrier F, Humbert M.
Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy.
Montani D, Girerd B, Günther S, Riant F, Tournier-Lasserve E, Magy L, Maazi N, Guignabert C, Savale L, Sitbon O, Simonneau G, Soubrier F, Humbert M.
Nat Genet. 2013 Dec 1. doi: 10.1038/ng.2844. [Epub ahead of print]
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmüller P, Fadel E, Sitbon O, Simonneau G, Tregouët DA, Humbert M, Soubrier F.
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, Chelghoum N, Coulet F, Bonnet D, Dorfmüller P, Fadel E, Sitbon O, Simonneau G, Tregouët DA, Humbert M, Soubrier F.
Eur Respir Rev. 2013 Dec 1;22(130):495-502. doi: 10.1183/09059180.00006413.
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
Preston IR, Suissa S, Humbert M.
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
Preston IR, Suissa S, Humbert M.
Clin Chest Med. 2013 Dec;34(4):867-80. doi: 10.1016/j.ccm.2013.08.002.
Novel medical therapies for pulmonary arterial hypertension.
O'Connell C, O'Callaghan DS, Humbert M.
Novel medical therapies for pulmonary arterial hypertension.
O'Connell C, O'Callaghan DS, Humbert M.
Circ Res. 2013 Dec 13. [Epub ahead of print]
Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension.
George PM, Oliver E, Dorfmüller P, Dubois OD, Reed DM, Kirkby NS, Mohamed NA, Perros F, Antigny F, Fadel E, Schreiber BE, Holmes A, Southwood M, Hagan G, Wort SJ, Bartlett N, Morrell NW, Coghlan G, Humbert M, Zhao L, Mitchell JA.
Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension.
George PM, Oliver E, Dorfmüller P, Dubois OD, Reed DM, Kirkby NS, Mohamed NA, Perros F, Antigny F, Fadel E, Schreiber BE, Holmes A, Southwood M, Hagan G, Wort SJ, Bartlett N, Morrell NW, Coghlan G, Humbert M, Zhao L, Mitchell JA.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9. doi: 10.1016/j.jacc.2013.10.023.
Pulmonary arterial hypertension: epidemiology and registries.
McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M.
Pulmonary arterial hypertension: epidemiology and registries.
McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D13-21. doi: 10.1016/j.jacc.2013.10.035.
Genetics and genomics of pulmonary arterial hypertension.
Soubrier F, Chung WK, Machado R, Grünig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M.
Genetics and genomics of pulmonary arterial hypertension.
Soubrier F, Chung WK, Machado R, Grünig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M.